Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis.

RATIONALE Mycobacterium tuberculosis is transmitted by infectious aerosols, but assessing infectiousness currently relies on sputum microscopy that does not accurately predict the variability in transmission. OBJECTIVES To evaluate the feasibility of collecting cough aerosols and the risk factors for infectious aerosol production from patients with pulmonary tuberculosis (TB) in a resource-limited setting. METHODS We enrolled subjects with suspected TB in Kampala, Uganda and collected clinical, radiographic, and microbiological data in addition to cough aerosol cultures. A subset of 38 subjects was studied on 2 or 3 consecutive days to assess reproducibility. MEASUREMENTS AND MAIN RESULTS M. tuberculosis was cultured from cough aerosols of 28 of 101 (27.7%; 95% confidence interval [CI], 19.9-37.1%) subjects with culture-confirmed TB, with a median 16 aerosol cfu (range, 1-701) in 10 minutes of coughing. Nearly all (96.4%) cultivable particles were 0.65 to 4.7 μm in size. Positive aerosol cultures were associated with higher Karnofsky performance scores (P = 0.016), higher sputum acid-fast bacilli smear microscopy grades (P = 0.007), lower days to positive in liquid culture (P = 0.004), stronger cough (P = 0.016), and fewer days on TB treatment (P = 0.047). In multivariable analyses, cough aerosol cultures were associated with a salivary/mucosalivary (compared with purulent/mucopurulent) appearance of sputum (odds ratio, 4.42; 95% CI, 1.23-21.43) and low days to positive (per 1-d decrease; odds ratio, 1.17; 95% CI, 1.07-1.33). The within-test (kappa, 0.81; 95% CI, 0.68-0.94) and interday test (kappa, 0.62; 95% CI, 0.43-0.82) reproducibility were high. CONCLUSIONS A minority of patients with TB (28%) produced culturable cough aerosols. Collection of cough aerosol cultures is feasible and reproducible in a resource-limited setting.

[1]  F. Tenover Developing molecular amplification methods for rapid diagnosis of respiratory tract infections caused by bacterial pathogens. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Ruth McNerney,et al.  Effectiveness of the Standard WHO Recommended Retreatment Regimen (Category II) for Tuberculosis in Kampala, Uganda: A Prospective Cohort Study , 2011, PLoS medicine.

[3]  Z. Ristovski,et al.  Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis , 2009, Thorax.

[4]  B. Alisjahbana,et al.  Insufficient quality of sputum submitted for tuberculosis diagnosis and associated factors, in Klaten district, Indonesia , 2009, BMC pulmonary medicine.

[5]  A. R. Escombe,et al.  The Infectiousness of Tuberculosis Patients Coinfected with HIV , 2008, PLoS medicine.

[6]  L. Tanoue Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa , 2008 .

[7]  S. Basu,et al.  Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study , 2007, The Lancet.

[8]  K. Fennelly Variability of airborne transmission of Mycobacterium tuberculosis: implications for control of tuberculosis in the HIV era. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  L. Lambert,et al.  Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[10]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[11]  M. King,et al.  A new paradigm in respiratory hygiene: increasing the cohesivity of airway secretions to improve cough interaction and reduce aerosol dispersion , 2005, BMC pulmonary medicine.

[12]  M. Molyneux,et al.  A Community-Based Study of the Incidence of Trimethoprim-Sulfamethoxazole-Preventable Infections in Malawian Adults Living With HIV , 2005, Journal of acquired immune deficiency syndromes.

[13]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[14]  V. Cook,et al.  Risk of tuberculosis in children from smear-negative source cases. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  W A Black,et al.  Transmission of tuberculosis from smear negative patients: a molecular epidemiology study , 2004, Thorax.

[16]  I. Orme,et al.  Cough-generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. , 2004, American journal of respiratory and critical care medicine.

[17]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[18]  D. Minnikin,et al.  Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum. , 2002, Microbiology.

[19]  N. Nagelkerke,et al.  Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases. , 2001, American journal of epidemiology.

[20]  M. Behr,et al.  Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli , 1999, The Lancet.

[21]  R. Urbanczik,et al.  The public health service national tuberculosis reference laboratory and the national laboratory network : minimum requirements, role and operation in a low-income country , 1998 .

[22]  D. Menzies Effect of Treatment on Contagiousness of Patients With Active Pulmonary Tuberculosis , 1997, Infection Control & Hospital Epidemiology.

[23]  C. Dye,et al.  Heterogeneities in the transmission of infectious agents: implications for the design of control programs. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Schoolnik,et al.  The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. , 1994, The New England journal of medicine.

[25]  D Alland,et al.  Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. , 1994, The New England journal of medicine.

[26]  T. Frieden,et al.  Tuberculosis transmission in the 1990s. , 1994, The New England journal of medicine.

[27]  L. Clancy,et al.  The pathogenicity of Mycobacterium tuberculosis during chemotherapy. , 1990, The European respiratory journal.

[28]  D. Snider,et al.  Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. , 2015, The American review of respiratory disease.

[29]  Cassidy Jt Tubercle bacilli retain pathogenicity after seven weeks chemotherapy. , 1981 .

[30]  J. Cassidy TUBERCLE BACILLI RETAIN PATHOGENICITY AFTER SEVEN WEEKS CHEMOTHERAPY , 1981, The Medical journal of Australia.

[31]  R. Noble Infectiousness of pulmonary tuberculosis after starting chemotherapy , 1981 .

[32]  A. Rouillon,et al.  Transmission of tubercle bacilli: The effects of chemotherapy. , 1976, Tubercle.

[33]  K. Stýblo,et al.  Results of contact examination in Rotterdam, 1967-1969. , 1975, Bulletin of the International Union against Tuberculosis.

[34]  W. Stead,et al.  Editorial: Effect of chemotherapy on infectiousness of tuberculosis. , 1974, The New England journal of medicine.

[35]  S. Brooks,et al.  A pilot study concerning the infection risk of sputum positive tuberculosis patients on chemotherapy. , 2015, The American review of respiratory disease.

[36]  R. Riley,et al.  Infectiousness of air from a tuberculosis ward. Ultraviolet irradiation of infected air: comparative infectiousness of different patients. , 1962, The American review of respiratory disease.

[37]  R. Riley,et al.  Tuberculosis disseminators. A study of the variability of aerial infectivity of tuberculous patients. , 1960, The American review of respiratory disease.

[38]  William Firth Wells,et al.  Airborne Contagion and Air Hygiene , 1955 .

[39]  R. Glover Infection of Mice with Mycobact. tuberculosis (Bovis) by the Respiratory Route , 1944 .